Skip to Content

WPI 900 (Glipizide Extended Release 2.5 mg)

Pill with imprint WPI 900 is Yellow, Round and has been identified as Glipizide Extended Release 2.5 mg. It is supplied by Watson Pharmaceuticals.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 900

Glipizide extended release 2.5 mg WPI 900
Glipizide extended release 2.5 mg WPI 900  Front
Glipizide extended release 2.5 mg WPI 900  Back
Glipizide extended release 2.5 mg WPI 900
Glipizide extended release 2.5 mg WPI 900

Glipizide Extended Release

Imprint:
WPI 900
Strength:
2.5 mg
Color:
Yellow
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-0900 Watson Pharmaceuticals, Inc.
68084-0295 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide